As a first-in-class selective HDAC6 inhibitor, ACY-1215 has been reported to have the effect to regulate cell apoptosis in tumor (Santo et al., 2012; Cao et al., 2018; Wang et al., 2018). The gene discussed is HDAC6; the disease is neoplasm.